Billette-de-Villemeur A, Poncet F, Garnier A, Marron J, Le Marc'hadour F, Morens A, Rouault-Plantaz V, Ney M, Exbrayat C
Service prospective et éducation pour la santé, conseil général de l'Isère, hôtel du département, 7, rue Fantin-Latour, BP 1096, 38022 Grenoble cedex 1, France.
Gynecol Obstet Fertil. 2009 Oct;37(10):787-95. doi: 10.1016/j.gyobfe.2009.04.027. Epub 2009 Sep 25.
The aim of this study is to compare to the guideline (1998 and 2001) the follow-up of Ascus cytological abnormalities among women aged 50-74 years who have participated at the combined breast, cervical and colorectal cancer screening programme from 1991 to 2000 in Isère, France.
The follow-up of 1154 women with Ascus smear was analysed. A woman was defined according follow-up if she have made a colposcopy or biopsy less than four months after one positive smear or if she has repeated three smears: 3-7 months and 10-14 months after the positive smear and 1 year after the last negative smear.
The follow-up was according to guidelines for 28.4% of the 1154 women (150 women are unknowns), 58.6% had a follow-up with too long delay and 17.2% had an uncompleted follow-up. The follow-up did not differ before 1998. It did not differ from women age. Women who were treated by gynaecologist (548) had a better follow-up (according: 35.4%) than the women who were treated by a general practitioner (595).
The follow-up of Ascus cytological abnormalities is not according to guideline. The follow-up in the screening program will be intensified.
本研究旨在将1991年至2000年参加法国伊泽尔省乳腺癌、宫颈癌和结直肠癌联合筛查项目的50至74岁女性中ascus细胞学异常的随访情况与指南（1998年和2001年）进行比较。
对1154例ascus涂片女性的随访情况进行分析。如果一名女性在一次阳性涂片后不到四个月进行了阴道镜检查或活检，或者她重复了三次涂片（阳性涂片后3至7个月、10至14个月以及最后一次阴性涂片后1年），则定义为有随访。
在1154名女性中（150名女性情况未知），28.4%的随访符合指南，58.6%的随访延迟过长，17.2%的随访未完成。1998年之前随访情况无差异。随访情况与女性年龄无关。由妇科医生治疗的女性（548名）的随访情况（符合：35.4%）比由全科医生治疗的女性（595名）更好。
ascus细胞学异常的随访未遵循指南。筛查项目中的随访将得到加强。
